Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-011553

Chief Business Development Off sold 16,250 shares at an average $64.64 ($1,050,381)

  • Chief Business Development Off acquired 16,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Business Development Off

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-16 Exercise or conversion : show line 1 in the form +16,250 $31.71 $515,288 16,250 D
2021-02-16 Sale : show line 2 in the form −5,022 $63.42 $318,495 11,228 D
2021-02-16 Sale : show line 3 in the form −1,700 $64.59 $109,803 9,528 D
2021-02-16 Sale : show line 4 in the form −9,528 $65.29 $622,083 0 D
Open-market sales · 16,250 sh · avg $64.64 · $1,050,381

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-16 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −16,250 48,750 D
Loading xslF345X03/doc4.xml…